Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs

H. D. Kleinert, M. Volpe, G. Odell, D. Marion, S. A. Atlas, M. J. Camargo, J. H. Laragh, T. Maack

Research output: Contribution to journalArticle

Abstract

Atrial natriuretic factor lowers blood pressure in normotensive and hypertensive animal models. The present study examined the mechanism of the blood pressure-lowering effect in 10 normotensive dogs. Four awake dogs previously instrumented with electromagnetic flow probes for measurement of cardiac output and catheters for systemic hemodynamic and cardiac dynamic measurements were studied. After a 30-minute control period, a 3 μg/kg bolus followed by 0.3 μg/min/kg of a 24-residue synthetic atrial natriuretic factor was infused for 30 minutes, followed by a 1-hour recovery period. Mean arterial pressure fell significantly during infusion (control, 125 ± 4; infusion, 108 ± 5; recovery, 125 ± 9 mm Hg; p <0.05) and was accompanied by a slight but significant bradycardia (control, 144 ± 7; infusion, 135 ± 5; recovery, 145 ± 7 beats/min; p <0.05). Significant reductions in cardiac output (control, 2.66 ± 0.60; infusion, 2.18 ± 0.60; recovery, 2.74 ± 0.60 L/min; p <0.05), stroke volume (control, 18.4 ± 3.9; infusion, 16.0 ± 4.2; recovery, 19.0 ± 3.7 ml/beat; p <0.05), and maximum increase in rate of change of left ventricular systolic pressure (control, 2475 ± 200; infusion, 2088 ± 216; recovery, 2487 ± 243 mm Hg/sec; p <0.05) were also observed during infusion. No significant changes in total peripheral resistance or central venous pressure were noted, although the latter tended to fall during infusion. A similar pattern was observed in six pentobarbital-anesthetized dogs, except that infusion of atrial natriuretic factor did not induce bradycardia. These data indicate that mean arterial pressure is lowered in these models by a mechanism other than reduction in total peripheral resistance, namely a reduction in cardiac output.

Original languageEnglish
Pages (from-to)312-316
Number of pages5
JournalHypertension
Volume8
Issue number4
Publication statusPublished - 1986

Fingerprint

Atrial Natriuretic Factor
Cardiac Output
Dogs
Bradycardia
Blood Pressure
Vascular Resistance
Arterial Pressure
Cardiac Catheters
Central Venous Pressure
Electromagnetic Phenomena
Ventricular Pressure
Pentobarbital
Stroke Volume
Animal Models
Hemodynamics

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Kleinert, H. D., Volpe, M., Odell, G., Marion, D., Atlas, S. A., Camargo, M. J., ... Maack, T. (1986). Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs. Hypertension, 8(4), 312-316.

Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs. / Kleinert, H. D.; Volpe, M.; Odell, G.; Marion, D.; Atlas, S. A.; Camargo, M. J.; Laragh, J. H.; Maack, T.

In: Hypertension, Vol. 8, No. 4, 1986, p. 312-316.

Research output: Contribution to journalArticle

Kleinert, HD, Volpe, M, Odell, G, Marion, D, Atlas, SA, Camargo, MJ, Laragh, JH & Maack, T 1986, 'Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs', Hypertension, vol. 8, no. 4, pp. 312-316.
Kleinert HD, Volpe M, Odell G, Marion D, Atlas SA, Camargo MJ et al. Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs. Hypertension. 1986;8(4):312-316.
Kleinert, H. D. ; Volpe, M. ; Odell, G. ; Marion, D. ; Atlas, S. A. ; Camargo, M. J. ; Laragh, J. H. ; Maack, T. / Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs. In: Hypertension. 1986 ; Vol. 8, No. 4. pp. 312-316.
@article{3f43708c634e447d8b45167a437e1fa8,
title = "Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs",
abstract = "Atrial natriuretic factor lowers blood pressure in normotensive and hypertensive animal models. The present study examined the mechanism of the blood pressure-lowering effect in 10 normotensive dogs. Four awake dogs previously instrumented with electromagnetic flow probes for measurement of cardiac output and catheters for systemic hemodynamic and cardiac dynamic measurements were studied. After a 30-minute control period, a 3 μg/kg bolus followed by 0.3 μg/min/kg of a 24-residue synthetic atrial natriuretic factor was infused for 30 minutes, followed by a 1-hour recovery period. Mean arterial pressure fell significantly during infusion (control, 125 ± 4; infusion, 108 ± 5; recovery, 125 ± 9 mm Hg; p <0.05) and was accompanied by a slight but significant bradycardia (control, 144 ± 7; infusion, 135 ± 5; recovery, 145 ± 7 beats/min; p <0.05). Significant reductions in cardiac output (control, 2.66 ± 0.60; infusion, 2.18 ± 0.60; recovery, 2.74 ± 0.60 L/min; p <0.05), stroke volume (control, 18.4 ± 3.9; infusion, 16.0 ± 4.2; recovery, 19.0 ± 3.7 ml/beat; p <0.05), and maximum increase in rate of change of left ventricular systolic pressure (control, 2475 ± 200; infusion, 2088 ± 216; recovery, 2487 ± 243 mm Hg/sec; p <0.05) were also observed during infusion. No significant changes in total peripheral resistance or central venous pressure were noted, although the latter tended to fall during infusion. A similar pattern was observed in six pentobarbital-anesthetized dogs, except that infusion of atrial natriuretic factor did not induce bradycardia. These data indicate that mean arterial pressure is lowered in these models by a mechanism other than reduction in total peripheral resistance, namely a reduction in cardiac output.",
author = "Kleinert, {H. D.} and M. Volpe and G. Odell and D. Marion and Atlas, {S. A.} and Camargo, {M. J.} and Laragh, {J. H.} and T. Maack",
year = "1986",
language = "English",
volume = "8",
pages = "312--316",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs

AU - Kleinert, H. D.

AU - Volpe, M.

AU - Odell, G.

AU - Marion, D.

AU - Atlas, S. A.

AU - Camargo, M. J.

AU - Laragh, J. H.

AU - Maack, T.

PY - 1986

Y1 - 1986

N2 - Atrial natriuretic factor lowers blood pressure in normotensive and hypertensive animal models. The present study examined the mechanism of the blood pressure-lowering effect in 10 normotensive dogs. Four awake dogs previously instrumented with electromagnetic flow probes for measurement of cardiac output and catheters for systemic hemodynamic and cardiac dynamic measurements were studied. After a 30-minute control period, a 3 μg/kg bolus followed by 0.3 μg/min/kg of a 24-residue synthetic atrial natriuretic factor was infused for 30 minutes, followed by a 1-hour recovery period. Mean arterial pressure fell significantly during infusion (control, 125 ± 4; infusion, 108 ± 5; recovery, 125 ± 9 mm Hg; p <0.05) and was accompanied by a slight but significant bradycardia (control, 144 ± 7; infusion, 135 ± 5; recovery, 145 ± 7 beats/min; p <0.05). Significant reductions in cardiac output (control, 2.66 ± 0.60; infusion, 2.18 ± 0.60; recovery, 2.74 ± 0.60 L/min; p <0.05), stroke volume (control, 18.4 ± 3.9; infusion, 16.0 ± 4.2; recovery, 19.0 ± 3.7 ml/beat; p <0.05), and maximum increase in rate of change of left ventricular systolic pressure (control, 2475 ± 200; infusion, 2088 ± 216; recovery, 2487 ± 243 mm Hg/sec; p <0.05) were also observed during infusion. No significant changes in total peripheral resistance or central venous pressure were noted, although the latter tended to fall during infusion. A similar pattern was observed in six pentobarbital-anesthetized dogs, except that infusion of atrial natriuretic factor did not induce bradycardia. These data indicate that mean arterial pressure is lowered in these models by a mechanism other than reduction in total peripheral resistance, namely a reduction in cardiac output.

AB - Atrial natriuretic factor lowers blood pressure in normotensive and hypertensive animal models. The present study examined the mechanism of the blood pressure-lowering effect in 10 normotensive dogs. Four awake dogs previously instrumented with electromagnetic flow probes for measurement of cardiac output and catheters for systemic hemodynamic and cardiac dynamic measurements were studied. After a 30-minute control period, a 3 μg/kg bolus followed by 0.3 μg/min/kg of a 24-residue synthetic atrial natriuretic factor was infused for 30 minutes, followed by a 1-hour recovery period. Mean arterial pressure fell significantly during infusion (control, 125 ± 4; infusion, 108 ± 5; recovery, 125 ± 9 mm Hg; p <0.05) and was accompanied by a slight but significant bradycardia (control, 144 ± 7; infusion, 135 ± 5; recovery, 145 ± 7 beats/min; p <0.05). Significant reductions in cardiac output (control, 2.66 ± 0.60; infusion, 2.18 ± 0.60; recovery, 2.74 ± 0.60 L/min; p <0.05), stroke volume (control, 18.4 ± 3.9; infusion, 16.0 ± 4.2; recovery, 19.0 ± 3.7 ml/beat; p <0.05), and maximum increase in rate of change of left ventricular systolic pressure (control, 2475 ± 200; infusion, 2088 ± 216; recovery, 2487 ± 243 mm Hg/sec; p <0.05) were also observed during infusion. No significant changes in total peripheral resistance or central venous pressure were noted, although the latter tended to fall during infusion. A similar pattern was observed in six pentobarbital-anesthetized dogs, except that infusion of atrial natriuretic factor did not induce bradycardia. These data indicate that mean arterial pressure is lowered in these models by a mechanism other than reduction in total peripheral resistance, namely a reduction in cardiac output.

UR - http://www.scopus.com/inward/record.url?scp=0022497057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022497057&partnerID=8YFLogxK

M3 - Article

C2 - 2937724

AN - SCOPUS:0022497057

VL - 8

SP - 312

EP - 316

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4

ER -